STRATEGY FOR DIAGNOSIS AND TREATMENT OF ALCOHOLIC LIVER DISEASE
- Authors: Polunina TE1, Polunina TE1
-
Affiliations:
- Issue: No 7 (2012)
- Pages: 58-63
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279498
- ID: 279498
Cite item
Full Text
Abstract
Alcoholic liver disease (ALD) remains the leading cause of complicated diseases of this organ and high mortality worldwide. In economically developed countries, cirrhosis is one of the leading causes of death in the working-age adults. Etiology of cirrhosis can not be determined approximately in 10-35 % of patients. Such observations are referred to as cryptogenic cirrhosis. In fact, alcohol may be the cause of these cirrhoses. Dependence on alcohol and alcohol withdrawal syndrome are rarely observed in most patients with ALD that allows them to drink alcohol in large quantities for many years. Until the formation of cirrhosis, subclinical course of ALD is very typical for these patients. Therefore, timely treatment and prevention of cirrhosis are impossible. The ademetionine (Heptral) is drug of choice for the treatment of ALD. Treatment schemes with ademetionine are determined by the current stage of ALD (alcoholic steatosis, alcoholic hepatitis and alcoholic cirrhosis).
Keywords
References
- Абдурахманов Д.Т. Алкогольная болезнь печени // Рос. журн. гастроэнтерол. гепатол., колопроктол. 2009. № 1. С. 4-10.
- Полунина Т.Е., Маев И.В. Полунина Е.В. Гепатология для практического врача. М., 2009. 340 с.
- Шерлок Ш., Дули Дж. Заболевания печени и желчных путей. М., 1999. 864 c.
- Arteel G, Mendez C, McClain C, et al. Advances in alcoholic liver disease. Best Pract Res Clin Gastroenterol 2003;17:625-47.
- Bellamy C, DiMartini A, Ruppert K, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001;72:619-26.
- Diehl A. Liver disease in alcohol abusers: clinical perspective. Alcohol 2002;27:7-11.
- Lieber C. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 2000;32:113-28.
- Lucey MR, Mathurin P, Morgan TR. Alcoholic Hepatitis. N Engl J Med 2009;360:2758-69.
- Madhotra R, Gilmore I. Recent developments in the treatment of alcoholic hepatitis. QJM 2003;96:391-400.
- Maher J. Alcoholic liver disease. In: Feldman M, Friedman L, ed. Sleisenger and Fordtran's gastrointestinal and liver disease: Pathophysiology, diagnosis and management. 7th ed. WB Saunders 2002:1375-91.
- Marsano L, Martin A, Randall H. Current nutrition in liver disease. Curr Opin Gastroenterol 2002;18:246-53.
- Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatology 2007;45(5):1306-12.
- Mendez C, Marsano L, Hill DB, McClain CJ. Alcoholic liver disease. Advanced Therapy in gastroenterology and liver disease. Bayless Theodore M., Diehl Anna Mae. 2005;115:665-670.
- Menon N, Gores G, Shah V. Pathogenesis, diagnosis and treatment of alcoholic liver disease. Mayo Clin Proc 2001;76:1021-29.
- Mezey E. Аlcoholic liver disease. Digestive disease library. The Johns Hopkins University, 2007.
- Stewart F, Day C. The management of alcoholic liver disease. J Hepatol 2003;38:2-13.
- Stickel B, Hoehn D, Schuppan H, et al. Review article: nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003;18:357-73.
Supplementary files
